Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2015

01-09-2015 | Article

Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm)

Authors: J. H. T. Wagenvoort, E. I. G. B. De Brauwer, R. J. R. Penders, C. J. van der Linden, R. J. Willems, J. Top, M. J. Bonten

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2015

Login to get access

Abstract

Ampicillin-resistant Enterococcus faecium (AREfm) has gained increased footholds in many hospital intensive care units (ICUs) and belongs to specific hospital-adapted E. faecium sub-populations. Three AREfm strains survived in an in vitro survival setting for approximately 5.5 years. These findings have important consequences for the epidemiology of AREfm in hospital settings and stress the importance of maintaining a good level of hospital hygiene.
Literature
1.
Top J, Schouls LM, Bonten MJ, Willems RJ (2004) Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 42:4503–4511PubMedCentralCrossRefPubMed
2.
Top J, Willems R, Blok H et al (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13:316–319CrossRefPubMed
3.
de Regt MJ, van der Wagen LE, Top J et al (2008) High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital. J Antimicrob Chemother 62:1401–1406CrossRefPubMed
4.
5.
Kluytmans-Vandenbergh MFQ, Kluytmans JAJW, Voss A (2005) Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 33:309–313CrossRefPubMed
6.
Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163:1905–1912CrossRefPubMed
7.
8.
Wagenvoort JHT, De Brauwer EIGB, Penders RJR, Willems RJ, Top J, Bonten MJ (2011) Environmental survival of vancomycin-resistant Enterococcus faecium. J Hosp Infect 77:282–283CrossRefPubMed
9.
Wagenvoort JHT, Sluijsmans W, Penders RJR (2000) Better environmental survival of outbreak vs. sporadic MRSA isolates. J Hosp Infect 45:231–234CrossRefPubMed
10.
Wagenvoort JHT, Penders RJR, Davies BI, Lütticken R (2005) Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity. Eur J Clin Microbiol Infect Dis 24:65–67CrossRefPubMed
Metadata
Title
Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm)
Authors
J. H. T. Wagenvoort
E. I. G. B. De Brauwer
R. J. R. Penders
C. J. van der Linden
R. J. Willems
J. Top
M. J. Bonten
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2430-x

Other articles of this Issue 9/2015

European Journal of Clinical Microbiology & Infectious Diseases 9/2015 Go to the issue

Article

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia

Article

Impact of borderline minimum inhibitory concentration on the outcome of invasive infections caused by Enterobacteriaceae treated with β-lactams: a systematic review and meta-analysis

Article

Colonisation of dentures by Staphylococcus aureus and MRSA in out-patient and in-patient populations

Article

Impact of round-the-clock CSF Gram stain on empirical therapy for suspected central nervous system infections

Article

Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy

Article

Evaluation of the PREVI® Isola automated seeder system compared to reference manual inoculation for antibiotic susceptibility testing by the disk diffusion method
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits